NeurologyLive Friday 5 — April 2, 2021
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 2, 2021.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: Insights: An Overview of Etiology and Prevalence of Pediatric MS
In this Insights series, "
2: NeuroVoices: Ralph Sacco, MD, MS, on Florida Stroke Registry, Advancing Stroke Knowledge
The chair of neurology and Olemberg Family Chair of Neurological Disorders at the University of Miami Miller School of Medicine discussed the abundance of research from the Florida Stroke Registry presented at ISC 2021.
3: Cure Connections: Patient Insight: Migraine Triggers
In this Cure Connections series, "
4: To Treat or Not to Treat: Secondary Progressive and Primary Progressive MS
Progressive forms of multiple sclerosis present a number of challenges for MS specialists, the biggest of which being whether or not disease-modifying therapy is required.
5: Clarifying Sleep Airflow Obstruction: William Noah, MD
The director and founder of the Sleep Centers of Middle Tennessee discussed the misleading nature of the term ‘sleep apnea' and pharmacological treatment for the condition that is currently being evaluated in phase 2 studies.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
- Pathophysiology of Myasthenia Gravis
September 18th 2025